Mode
Text Size
Log in / Sign up
N/A N=202 Randomized Health Services Research

Pregnancy-Related Hypertension: Adherence to a New Type of Monitoring

Gestational Hypertension · Preeclampsia · Chronic Hypertension With Pre-Eclampsia Complicating Childbirth · HELLP Syndrome

Enrolled (actual)
202
Serious AEs
0.0%
Results posted
May 2023
Primary outcome: Primary: Adherence to the American College of Obstetricians and Gynecologists Guideline of Postpartum Blood Pressure Check Within 10 Days Postpartum — 59; 89 Participants — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Home blood pressure monitoring (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
Female
Sponsor
Prisma Health-Upstate
Primary completion
Jan 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Adherence to the American College of Obstetricians and Gynecologists Guideline of Postpartum Blood Pressure Check Within 10 Days Postpartum
59; 89 <0.001 sig
SECONDARY
Initiation of Antihypertensive After Discharge
7; 9 .530
SECONDARY
Unscheduled Visits
5; 12 .059
SECONDARY
Readmission
5; 4 .792
SECONDARY
Attended Postpartum Visit
71; 75 .210

Summary

A large segment of our patient population is diagnosed with hypertensive disorders of pregnancy, including gestational hypertension and pre-eclampsia. New guidelines from the American College of Obstetricians and Gynecologists recommend postpartum monitoring of blood pressures via blood pressure checks on day 3 postpartum and between days 7-10 postpartum. Our purpose is to compare the effectiveness of using a Bluetooth-enabled home blood pressure monitoring platform to the standard postpartum office-based blood pressure monitoring in performing the recommended postpartum follow-up for patients with hypertensive disorders of pregnancy.

Eligibility Criteria

Inclusion Criteria

  • Patient must have delivered an infant either at Greenville Memorial Hospital or MUSC and be willing and able to follow-up with her respective institution.
  • Patient must have been diagnosed with a hypertensive disorder of pregnancy in the antepartum, intrapartum, or postpartum period.

Exclusion Criteria

  • 50 (due to limitations in blood pressure cuff size through BabyScripts)
  • non English-speaking
  • not able to receive phone calls and unlimited texts on cell phone
  • not able to download and use Babyscripts phone application
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04823949). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search